Kiltearn Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.51M Sell
97,403
-4,897
-5% -$357K 1.82% 19
2026
Q1
$6.68M Buy
102,300
+23,391
+30% +$1.74M 1.8% 19
2025
Q4
$6.25M Sell
78,909
-14,091
-15% -$1.08M 1.35% 22
2025
Q3
$6.79M Sell
93,000
-6,500
-7% -$476K 1.36% 23
2025
Q2
$7.55M Sell
99,500
-1,100
-1% -$77.9K 1.52% 21
2025
Q1
$7.65M Buy
100,600
+27,100
+37% +$2.02M 1.46% 22
2024
Q4
$4.86M Buy
73,500
+32,800
+81% +$2.3M 0.8% 31
2024
Q3
$2.84M Buy
+40,700
New +$2.45M 0.39% 33

Other funds holding SOLV

Kiltearn Partners's SOLV Position: Q2 2026 in Review

Kiltearn Partners reduced its Solventum (SOLV) stake by 4.8% in Q2 2026, selling an estimated $357K and leaving 97,403 shares worth $7.51M. The position accounts for 1.82% of the portfolio, ranked #19.

Kiltearn Partners first reported a position in SOLV in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.65M in Q1 2025. 883 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Kiltearn Partners held 97,403 shares of Solventum worth $7.51M as of Q2 2026.
  • Kiltearn Partners sold 4,897 Solventum shares in Q2 2026, an estimated $357K.
  • Solventum made up 1.82% of Kiltearn Partners's portfolio in Q2 2026, its #19 holding.
  • Kiltearn Partners first reported a position in Solventum in Q3 2024 and has held it in 8 quarters since.
  • Kiltearn Partners's Solventum position peaked at $7.65M in Q1 2025.
  • 883 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Kiltearn Partners's 13F filing for Q2 2026, filed 12 Aug 2026.